Ţiţ et al., 2017 - Google Patents
Somatic-vegetative symptoms evolution in postmenopausal women treated with phytoestrogens and hormone replacement therapyŢiţ et al., 2017
View HTML- Document ID
- 679205867745512514
- Author
- Ţiţ D
- Pallag A
- Iovan C
- Furău G
- Furău C
- Bungău S
- Publication year
- Publication venue
- Iranian Journal of Public Health
External Links
Snippet
Background: The purpose of this study was to compare the effects of the phytoestrogens in relieving and/or suppressing the specific somatic-vegetative symptoms of menopause with those of the hormone therapy, administered in small doses. Methods: The study was …
- 239000003075 phytoestrogen 0 title abstract description 41
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. cannabinols, methantheline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane, progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/32—Medical data management, e.g. systems or protocols for archival or communication of medical images, computerised patient records or computerised general medical references
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING; COUNTING
- G06F—ELECTRICAL DIGITAL DATA PROCESSING
- G06F19/00—Digital computing or data processing equipment or methods, specially adapted for specific applications
- G06F19/30—Medical informatics, i.e. computer-based analysis or dissemination of patient or disease data
- G06F19/34—Computer-assisted medical diagnosis or treatment, e.g. computerised prescription or delivery of medication or diets, computerised local control of medical devices, medical expert systems or telemedicine
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Ţiţ et al. | Somatic-vegetative symptoms evolution in postmenopausal women treated with phytoestrogens and hormone replacement therapy | |
Braverman | Premenstrual syndrome and premenstrual dysphoric disorder | |
Pitkin | Alternative and complementary therapies for the menopause | |
Panay et al. | The 2013 British menopause society & women’s health concern recommendations on hormone replacement therapy | |
Hendrix et al. | Effects of estrogen with and without progestin on urinary incontinence | |
Carmignani et al. | The effect of dietary soy supplementation compared to estrogen and placebo on menopausal symptoms: a randomized controlled trial | |
Panay | Management of premenstrual syndrome: evidence-based guidelines | |
Roberts | Managing the menopause | |
Park et al. | North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes | |
Lewis | Undertreatment of menopausal symptoms and novel options for comprehensive management | |
Ortmann et al. | Hormone therapy in perimenopause and postmenopause (HT) Interdisciplinary S3 Guideline, Association of the Scientific Medical Societies in Germany AWMF 015/062-short version | |
Rattanatantikul et al. | Efficacy and safety of nutraceutical on menopausal symptoms in post-menopausal women: a randomized, double-blind, placebo-controlled clinical trial | |
Kazemi et al. | The effect of evening primrose oil capsule on hot flashes and night sweats in postmenopausal women: a single-blind randomized controlled trial | |
Panay | Management of premenstrual syndrome | |
Zhou et al. | Chinese herbal medicine Kuntai capsule for treatment of menopausal syndrome: a systematic review of randomized clinical trials | |
Hu et al. | Detection of a negative correlation between prescription of Chinese herbal products containing coumestrol, genistein or daidzein and risk of subsequent endometrial cancer among tamoxifen-treated female breast cancer survivors in Taiwan between 1998 and 2008: A population-based study | |
Ziller et al. | The prescribing of contraceptives for adolescents in German gynecologic practices in 2007 and 2011: a retrospective database analysis | |
Chalkidou et al. | The comparative study of the administration of the combination preparation of Isoflavones and hyaluronic acid in menopausal women for the treatment of the symptoms of menopause, urogenital atrophy and oteoporosis in relation to existing hormone replacement therapies | |
Joy et al. | Black cohosh: a cause of abnormal postmenopausal liver function tests | |
Rees | Management of the menopause: integrated health-care pathway for the menopausal woman | |
Lin et al. | A randomized, double-blind, placebo-controlled trial assessing the efficacy and safety of tegaserod in patients from China with chronic constipation | |
Gainford et al. | A practical guide to the management of menopausal symptoms in breast cancer patients | |
Trimarco et al. | Effects of a new combination of nutraceuticals on postmenopausal symptoms and metabolic profile: a crossover, randomized, double-blind trial | |
Alexandersen et al. | Long-term prevention with hormone-replacement therapy after the menopause: which women should be targeted? | |
Aslan et al. | How best is to discontinue postmenopausal hormone therapy: immediate or tapered? |